Dicerna Pharmaceuticals

Dicerna

Investment Calculator

Banner Image
Investors & MediaStock InformationInvestment Calculator

Investment Calculator

ERROR

Return calculations do not include reinvested cash dividends.

Data Provided by Refinitiv. Minimum 15 minutes delayed.

Our mission

We interfere with disease

We use RNA interference, or RNAi, to create medicines that silence the genes that cause or contribute to disease. Our goal is to provide life-changing therapies to people living with rare and common diseases.

X
logo

Effective 28 December 2021 Dicerna Pharmaceuticals, Inc. is a wholly owned subsidiary of Novo Nordisk A/S

 

 

PRESS RELEASE
CONTINUE TO DICERNA.COM
VISIT NOVONORDISK.COM